In spite of the beneficial effects reported by other authors, and within the limitations of this experimental study, it can be concluded that local administration of 4 μg of IGF-I is not able to enhance the osseointegration process neither in the non-osteoporotic group nor in the osteoporosis animal model. The gene discussed is IGF1; the disease is osteoporosis.